These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


248 related items for PubMed ID: 17261491

  • 1. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE, Foster EM, Robb JA.
    Ambul Pediatr; 2007; 7(1 Suppl):121-31. PubMed ID: 17261491
    [Abstract] [Full Text] [Related]

  • 2. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents.
    Pelham WE, Foster EM, Robb JA.
    J Pediatr Psychol; 2007 Jul; 32(6):711-27. PubMed ID: 17556402
    [Abstract] [Full Text] [Related]

  • 3. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.
    Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR.
    Curr Med Res Opin; 2005 Feb; 21(2):195-206. PubMed ID: 15801990
    [Abstract] [Full Text] [Related]

  • 4. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.
    Doshi JA, Hodgkins P, Kahle J, Sikirica V, Cangelosi MJ, Setyawan J, Erder MH, Neumann PJ.
    J Am Acad Child Adolesc Psychiatry; 2012 Oct; 51(10):990-1002.e2. PubMed ID: 23021476
    [Abstract] [Full Text] [Related]

  • 5. Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity.
    Ray GT, Levine P, Croen LA, Bokhari FA, Hu TW, Habel LA.
    Arch Pediatr Adolesc Med; 2006 Oct; 160(10):1063-9. PubMed ID: 17018466
    [Abstract] [Full Text] [Related]

  • 6. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.
    Biederman J.
    J Clin Psychiatry; 2004 Oct; 65 Suppl 3():3-7. PubMed ID: 15046528
    [Abstract] [Full Text] [Related]

  • 7. Attention-deficit/hyperactivity disorder: increased costs for patients and their families.
    Swensen AR, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, Claxton A.
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1415-23. PubMed ID: 14627876
    [Abstract] [Full Text] [Related]

  • 8. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm.
    Kessler RC, Lane M, Stang PE, Van Brunt DL.
    Psychol Med; 2009 Jan; 39(1):137-47. PubMed ID: 18423074
    [Abstract] [Full Text] [Related]

  • 9. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME, Lapane KL.
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [Abstract] [Full Text] [Related]

  • 10. Children and adolescents with attention deficit-hyperactivity disorder: 1. Prevalence and cost of care.
    Burd L, Klug MG, Coumbe MJ, Kerbeshian J.
    J Child Neurol; 2003 Aug; 18(8):555-61. PubMed ID: 13677583
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan.
    Polanczyk G, Rohde LA.
    Curr Opin Psychiatry; 2007 Jul; 20(4):386-92. PubMed ID: 17551354
    [Abstract] [Full Text] [Related]

  • 12. The search for biomarkers for attention deficit/hyperactivity disorder.
    Wallis D.
    Drug News Perspect; 2010 Sep; 23(7):438-49. PubMed ID: 20862396
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of ADHD in school-age children.
    Scahill L, Schwab-Stone M.
    Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):541-55, vii. PubMed ID: 10944656
    [Abstract] [Full Text] [Related]

  • 14. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
    Schein J, Adler LA, Childress A, Cloutier M, Gagnon-Sanschagrin P, Davidson M, Kinkead F, Guerin A, Lefebvre P.
    J Med Econ; 2022 Jul; 25(1):193-205. PubMed ID: 35068300
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.
    Quintero J, Ramos-Quiroga JA, Sebastián JS, Montañés F, Fernández-Jaén A, Martínez-Raga J, Giral MG, Graell M, Mardomingo MJ, Soutullo C, Eiris J, Téllez M, Pamias M, Correas J, Sabaté J, García-Orti L, Alda JA.
    BMC Psychiatry; 2018 Feb 08; 18(1):40. PubMed ID: 29422022
    [Abstract] [Full Text] [Related]

  • 17. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun 08; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 18. The consequences of attention-deficit/hyperactivity disorder in adults.
    Goodman DW.
    J Psychiatr Pract; 2007 Sep 08; 13(5):318-27. PubMed ID: 17890980
    [Abstract] [Full Text] [Related]

  • 19. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association.
    Diabetes Care; 2008 Mar 08; 31(3):596-615. PubMed ID: 18308683
    [Abstract] [Full Text] [Related]

  • 20. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN, Lesesne CA, Perou R.
    Pediatrics; 2007 Feb 08; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.